In agreement with these data, and with the SMYD3 role in regulating the cell cycle related gene, we have shown that SMYD3 is required for proper S phase completion in different types of tumor cells (CRC, lung, pancreatic, ovarian and prostate cancer) (Table 2) [40]. Here, SMYD3 is linked to prostate carcinoma.